Advertisement

Index by author

May 01, 2002; Volume 30,Issue 5

A

  1. Anderson, Bradley D.

    1. Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
      Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
      Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479

  2. Andersson, Paul

    1. Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
      Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
      Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582

  3. Ariyoshi, Noritaka

    1. Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534

B

  1. Baillie, Thomas A.

    1. Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505

  2. Blumer, Jeffrey L.

    1. 3-O-Methyldobutamine, a Major Metabolite of Dobutamine in Humans
      Maohe Yan, Leslie T. Webster and Jeffrey L. Blumer
      Drug Metabolism and Disposition May 2002, 30 (5) 519-524; DOI: https://doi.org/10.1124/dmd.30.5.519

  3. Bode, W.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  4. Born, Stephanie L.

    1. Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation
      Stephanie L. Born, Douglas Caudill, Kristine L. Fliter and Michael P. Purdon
      Drug Metabolism and Disposition May 2002, 30 (5) 483-487; DOI: https://doi.org/10.1124/dmd.30.5.483

  5. Bosron, William F.

    1. Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488

  6. Buckley, Arthur R.

    1. Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608

  7. Buckley, Donna J.

    1. Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608

C

  1. Caudill, Douglas

    1. Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation
      Stephanie L. Born, Douglas Caudill, Kristine L. Fliter and Michael P. Purdon
      Drug Metabolism and Disposition May 2002, 30 (5) 483-487; DOI: https://doi.org/10.1124/dmd.30.5.483

  2. Crespi, Charles

    1. Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595

D

  1. Desai, Pankaj B.

    1. Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608

  2. Desta, Zeruesenay

    1. Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
      James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
      Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525

  3. Ding, Xinxin

    1. Expression of the Rat CYP2A3 Gene in Transgenic Mice
      Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
      Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548

  4. Du, Bert N. La

    1. Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488

E

  1. Edwards, Jeffrey E.

    1. Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
      Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
      Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479

F

  1. Falany, Charles N.

    1. Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
      Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
      Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582

  2. Fang, Xiaojun

    1. Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505

  3. Fitzpatrick, Jennifer L.

    1. Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
      Sharon L. Ripp, Jennifer L. Fitzpatrick, Jeffrey M. Peters and Russell A. Prough
      Drug Metabolism and Disposition May 2002, 30 (5) 570-575; DOI: https://doi.org/10.1124/dmd.30.5.570

  4. Fliter, Kristine L.

    1. Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation
      Stephanie L. Born, Douglas Caudill, Kristine L. Fliter and Michael P. Purdon
      Drug Metabolism and Disposition May 2002, 30 (5) 483-487; DOI: https://doi.org/10.1124/dmd.30.5.483

  5. Flockhart, David A.

    1. Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
      James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
      Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525

  6. Furuta, Shigeru

    1. Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
      Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
      Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498

G

  1. Gaedigk, Andrea

    1. Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595

  2. Goodwin, Bryan J.

    1. Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608

H

  1. Hendrickx, J.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  2. Hosokawa, Masakiyo

    1. Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488

  3. Hsieh, Faye

    1. Glucuronidation versus Oxidation of the Flavonoid Galangin by Human Liver Microsomes and Hepatocytes
      Yoko Otake, Faye Hsieh and Thomas Walle
      Drug Metabolism and Disposition May 2002, 30 (5) 576-581; DOI: https://doi.org/10.1124/dmd.30.5.576

I

  1. Igarashi, Takashi

    1. Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534

  2. Ishii, Itsuko

    1. Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534

  3. Ishii, Mikio

    1. Structure-Activity Relationship inO-Glucuronidation of Indolocarbazole Analogs
      Norihiro Takenaga, Mikio Ishii, Toshio Kamei and Toshio Yasumori
      Drug Metabolism and Disposition May 2002, 30 (5) 494-497; DOI: https://doi.org/10.1124/dmd.30.5.494

K

  1. Kamei, Toshio

    1. Structure-Activity Relationship inO-Glucuronidation of Indolocarbazole Analogs
      Norihiro Takenaga, Mikio Ishii, Toshio Kamei and Toshio Yasumori
      Drug Metabolism and Disposition May 2002, 30 (5) 494-497; DOI: https://doi.org/10.1124/dmd.30.5.494

  2. Kawabata, Yoshihiro

    1. Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
      Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
      Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498

  3. Kitada, Mitsukazu

    1. Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534

  4. Kothare, Prajakti A.

    1. Intestinal Metabolism: The Role of Enzyme Localization in Phenol Metabolite Kinetics
      Prajakti A. Kothare and Cheryl L. Zimmerman
      Drug Metabolism and Disposition May 2002, 30 (5) 586-594; DOI: https://doi.org/10.1124/dmd.30.5.586

  5. Kurimoto, Tadashi

    1. Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
      Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
      Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498

L

  1. Lavrijsen, K.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  2. Leeder, J. Steven

    1. Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595

  3. Leempoels, J.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  4. Le Jeune, L.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  5. Lin, Jiunn H.

    1. Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505

  6. Little, Joanna M.

    1. Glucuronidation of the Dietary Fatty Acids, Phytanic Acid and Docosahexaenoic Acid, by Human UDP-Glucuronosyltransferases
      Joanna M. Little, Lisa Williams, Jing Xu and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2002, 30 (5) 531-533; DOI: https://doi.org/10.1124/dmd.30.5.531

  7. Liu, Lan

    1. Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression
      Mingxing Xie, Dongfang Yang, Lan Liu, Bob Xue and Bingfang Yan
      Drug Metabolism and Disposition May 2002, 30 (5) 541-547; DOI: https://doi.org/10.1124/dmd.30.5.541

M

  1. Ma, Bennett

    1. Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505

  2. Mannens, G. S. J.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  3. Marcucci, Kenda A.

    1. Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595

  4. McNamara, Patrick J.

    1. Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
      Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
      Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479

  5. Meloche, Connie A.

    1. Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
      Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
      Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582

  6. Meuldermans, W.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  7. Miyazawa, Mitsuo

    1. Metabolism of (+)- and (−)-Limonenes to Respective Carveols and Perillyl Alcohols by CYP2C9 and CYP2C19 in Human Liver Microsomes
      Mitsuo Miyazawa, Masaki Shindo and Tsutomu Shimada
      Drug Metabolism and Disposition May 2002, 30 (5) 602-607; DOI: https://doi.org/10.1124/dmd.30.5.602

  8. Moore, Linda B.

    1. Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608

  9. Morgan, Michael E.

    1. Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
      Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
      Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479

N

  1. Nakamura, Hiroyoshi

    1. Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534

  2. Nakasa, Hiromitsu

    1. Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534

  3. Nallani, Srikanth C.

    1. Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608

  4. Nishigaki, Ryuichiro

    1. Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
      Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
      Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498

O

  1. Ohmori, Shigeru

    1. Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534

  2. Otake, Yoko

    1. Glucuronidation versus Oxidation of the Flavonoid Galangin by Human Liver Microsomes and Hepatocytes
      Yoko Otake, Faye Hsieh and Thomas Walle
      Drug Metabolism and Disposition May 2002, 30 (5) 576-581; DOI: https://doi.org/10.1124/dmd.30.5.576

P

  1. Pearce, Robin E.

    1. Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595

  2. Pearson, Paul G.

    1. Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505

  3. Peters, Jeffrey M.

    1. Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
      Sharon L. Ripp, Jennifer L. Fitzpatrick, Jeffrey M. Peters and Russell A. Prough
      Drug Metabolism and Disposition May 2002, 30 (5) 570-575; DOI: https://doi.org/10.1124/dmd.30.5.570

  4. Prough, Russell A.

    1. Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
      Sharon L. Ripp, Jennifer L. Fitzpatrick, Jeffrey M. Peters and Russell A. Prough
      Drug Metabolism and Disposition May 2002, 30 (5) 570-575; DOI: https://doi.org/10.1124/dmd.30.5.570

  5. Prueksaritanont, Thomayant

    1. Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505

  6. Purdon, Michael P.

    1. Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation
      Stephanie L. Born, Douglas Caudill, Kristine L. Fliter and Michael P. Purdon
      Drug Metabolism and Disposition May 2002, 30 (5) 483-487; DOI: https://doi.org/10.1124/dmd.30.5.483

Q

  1. Qiu, Yue

    1. Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505

R

  1. Radominska-Pandya, Anna

    1. Glucuronidation of the Dietary Fatty Acids, Phytanic Acid and Docosahexaenoic Acid, by Human UDP-Glucuronosyltransferases
      Joanna M. Little, Lisa Williams, Jing Xu and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2002, 30 (5) 531-533; DOI: https://doi.org/10.1124/dmd.30.5.531

  2. Rae, James M.

    1. Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
      James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
      Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525

  3. Ripp, Sharon L.

    1. Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
      Sharon L. Ripp, Jennifer L. Fitzpatrick, Jeffrey M. Peters and Russell A. Prough
      Drug Metabolism and Disposition May 2002, 30 (5) 570-575; DOI: https://doi.org/10.1124/dmd.30.5.570

S

  1. Sane, Rucha S.

    1. Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608

  2. Sanghani, Sonal P.

    1. Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488

  3. Satoh, Tetsuo

    1. Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488

  4. Savolainen, Jouko

    1. Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
      Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
      Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479

  5. Sharma, Vyas

    1. Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
      Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
      Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582

  6. Shimada, Tsutomu

    1. Metabolism of (+)- and (−)-Limonenes to Respective Carveols and Perillyl Alcohols by CYP2C9 and CYP2C19 in Human Liver Microsomes
      Mitsuo Miyazawa, Masaki Shindo and Tsutomu Shimada
      Drug Metabolism and Disposition May 2002, 30 (5) 602-607; DOI: https://doi.org/10.1124/dmd.30.5.602

  7. Shindo, Masaki

    1. Metabolism of (+)- and (−)-Limonenes to Respective Carveols and Perillyl Alcohols by CYP2C9 and CYP2C19 in Human Liver Microsomes
      Mitsuo Miyazawa, Masaki Shindo and Tsutomu Shimada
      Drug Metabolism and Disposition May 2002, 30 (5) 602-607; DOI: https://doi.org/10.1124/dmd.30.5.602

  8. Shinozaki, Yutaka

    1. Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
      Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
      Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498

  9. Snel, C. A. W.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  10. Soukhova, Nadia V.

    1. Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
      James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
      Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525

  11. Steimel, Dorothy T.

    1. Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595

  12. Su, Ting

    1. Expression of the Rat CYP2A3 Gene in Transgenic Mice
      Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
      Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548

  13. Subramanian, Raju

    1. Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505

  14. Swedmark, Stellan

    1. Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
      Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
      Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582

  15. Swiatek, Pam

    1. Expression of the Rat CYP2A3 Gene in Transgenic Mice
      Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
      Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548

T

  1. Takenaga, Norihiro

    1. Structure-Activity Relationship inO-Glucuronidation of Indolocarbazole Analogs
      Norihiro Takenaga, Mikio Ishii, Toshio Kamei and Toshio Yasumori
      Drug Metabolism and Disposition May 2002, 30 (5) 494-497; DOI: https://doi.org/10.1124/dmd.30.5.494

  2. Taylor, Eve M.

    1. Neotrofin Is Transported Out of Brain by a Saturable Mechanism: Possible Involvement of Multidrug Resistance and Monocarboxylic Acid Transporters
      Rongzi Yan and Eve M. Taylor
      Drug Metabolism and Disposition May 2002, 30 (5) 513-518; DOI: https://doi.org/10.1124/dmd.30.5.513

  3. Taylor, Palmer

    1. Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488

V

  1. van Beijsterveldt, L.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  2. Van Osselaer, N.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  3. Van Peer, A.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  4. Verhaeghe, T.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

W

  1. Walle, Thomas

    1. Induction of Human UDP-Glucuronosyltransferase UGT1A1 by Flavonoids—Structural Requirements
      U. Kristina Walle and Thomas Walle
      Drug Metabolism and Disposition May 2002, 30 (5) 564-569; DOI: https://doi.org/10.1124/dmd.30.5.564
    2. Glucuronidation versus Oxidation of the Flavonoid Galangin by Human Liver Microsomes and Hepatocytes
      Yoko Otake, Faye Hsieh and Thomas Walle
      Drug Metabolism and Disposition May 2002, 30 (5) 576-581; DOI: https://doi.org/10.1124/dmd.30.5.576

  2. Walle, U. Kristina

    1. Induction of Human UDP-Glucuronosyltransferase UGT1A1 by Flavonoids—Structural Requirements
      U. Kristina Walle and Thomas Walle
      Drug Metabolism and Disposition May 2002, 30 (5) 564-569; DOI: https://doi.org/10.1124/dmd.30.5.564

  3. Webster, Leslie T.

    1. 3-O-Methyldobutamine, a Major Metabolite of Dobutamine in Humans
      Maohe Yan, Leslie T. Webster and Jeffrey L. Blumer
      Drug Metabolism and Disposition May 2002, 30 (5) 519-524; DOI: https://doi.org/10.1124/dmd.30.5.519

  4. Williams, Lisa

    1. Glucuronidation of the Dietary Fatty Acids, Phytanic Acid and Docosahexaenoic Acid, by Human UDP-Glucuronosyltransferases
      Joanna M. Little, Lisa Williams, Jing Xu and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2002, 30 (5) 531-533; DOI: https://doi.org/10.1124/dmd.30.5.531

X

  1. Xie, Mingxing

    1. Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression
      Mingxing Xie, Dongfang Yang, Lan Liu, Bob Xue and Bingfang Yan
      Drug Metabolism and Disposition May 2002, 30 (5) 541-547; DOI: https://doi.org/10.1124/dmd.30.5.541

  2. Xu, Jing

    1. Glucuronidation of the Dietary Fatty Acids, Phytanic Acid and Docosahexaenoic Acid, by Human UDP-Glucuronosyltransferases
      Joanna M. Little, Lisa Williams, Jing Xu and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2002, 30 (5) 531-533; DOI: https://doi.org/10.1124/dmd.30.5.531

  3. Xue, Bob

    1. Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression
      Mingxing Xie, Dongfang Yang, Lan Liu, Bob Xue and Bingfang Yan
      Drug Metabolism and Disposition May 2002, 30 (5) 541-547; DOI: https://doi.org/10.1124/dmd.30.5.541

Y

  1. Yan, Bingfang

    1. Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression
      Mingxing Xie, Dongfang Yang, Lan Liu, Bob Xue and Bingfang Yan
      Drug Metabolism and Disposition May 2002, 30 (5) 541-547; DOI: https://doi.org/10.1124/dmd.30.5.541

  2. Yan, Maohe

    1. 3-O-Methyldobutamine, a Major Metabolite of Dobutamine in Humans
      Maohe Yan, Leslie T. Webster and Jeffrey L. Blumer
      Drug Metabolism and Disposition May 2002, 30 (5) 519-524; DOI: https://doi.org/10.1124/dmd.30.5.519

  3. Yan, Rongzi

    1. Neotrofin Is Transported Out of Brain by a Saturable Mechanism: Possible Involvement of Multidrug Resistance and Monocarboxylic Acid Transporters
      Rongzi Yan and Eve M. Taylor
      Drug Metabolism and Disposition May 2002, 30 (5) 513-518; DOI: https://doi.org/10.1124/dmd.30.5.513

  4. Yang, Dongfang

    1. Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression
      Mingxing Xie, Dongfang Yang, Lan Liu, Bob Xue and Bingfang Yan
      Drug Metabolism and Disposition May 2002, 30 (5) 541-547; DOI: https://doi.org/10.1124/dmd.30.5.541

  5. Yasumori, Toshio

    1. Structure-Activity Relationship inO-Glucuronidation of Indolocarbazole Analogs
      Norihiro Takenaga, Mikio Ishii, Toshio Kamei and Toshio Yasumori
      Drug Metabolism and Disposition May 2002, 30 (5) 494-497; DOI: https://doi.org/10.1124/dmd.30.5.494

Z

  1. Zhang, Jianhua

    1. Expression of the Rat CYP2A3 Gene in Transgenic Mice
      Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
      Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548

  2. Zhang, Qing-Yu

    1. Expression of the Rat CYP2A3 Gene in Transgenic Mice
      Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
      Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548

  3. Zimmerman, Cheryl L.

    1. Intestinal Metabolism: The Role of Enzyme Localization in Phenol Metabolite Kinetics
      Prajakti A. Kothare and Cheryl L. Zimmerman
      Drug Metabolism and Disposition May 2002, 30 (5) 586-594; DOI: https://doi.org/10.1124/dmd.30.5.586
Back to top

In this issue

Advertisement